After identifying RKIP-regulated signaling networks in tumors and their microenvironment, the Rosner group generated several RKIP pathway-based gene signatures for predicting metastasis-free survival of breast cancer patients [6,7,8,9,10]. Here, PEBP1 is linked to breast carcinoma.